Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a dismal prognosis. The average life expectancy of untreated patients with IPF is only 3 to 4 years. Decline in forced vital capacity (FVC) in patients with IPF appears to be almost linear, with patients with well-preserved FVC at bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Maher, Toby M., Strek, Mary E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731623/
https://www.ncbi.nlm.nih.gov/pubmed/31492155
http://dx.doi.org/10.1186/s12931-019-1161-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731623/
https://www.ncbi.nlm.nih.gov/pubmed/31492155
http://dx.doi.org/10.1186/s12931-019-1161-4

Ejemplares similares